TG Therapeutics is gearing up for a new clinical trial, dubbed ULTIMATE, to test Briumvi in children and adolescents with ...

When an insurance denial blocks guest writer Denise Schnieders from getting an MS disease activity test, she decides to fight back.

New clinical trial data suggest vidofludimus calcium can target key mechanisms underlying progressive multiple sclerosis.

Columnist Ben Hofmeister has just completed his third overnight sleep study in three years as part of an effort to control sleep apnea.

People with MS who engage in more physical activity tend to have less severe physical and cognitive disability, a study demonstrated.

Presentation raises questions about EBV timing. Dalia Rotstein, MD, of the University of Toronto, discussed the findings and their implications in an oral presentation at the Amer ...

MS pain is the uninvited guest you can't turn away, columnist Desiree Lama writes. Listening to your body is the key to ...

Bazedoxifene, a drug that alters the activity of the sex hormone estrogen, failed to promote myelin repair in women with MS, a study found.

In people with early MS, diet may correlate with biological aging and the development of disease-related disability, study ...